Randomized, double-blind pilot trial comparing lamotrigine versus citalopram for the treatment of bipolar depression

被引:51
作者
Schaffer, Ayal [1 ]
Zuker, Pamela [1 ]
Levitt, Anthony [1 ]
机构
[1] Univ Toronto, Sunnybrook Hlth Sci Ctr, Mood Disorders Program, Dept Psychiat, Toronto, ON M4N 3M5, Canada
关键词
bipolar disorder; bipolar depression; lamotrigine; citalopram; antidepressant; mood stabilizer;
D O I
10.1016/j.jad.2006.05.023
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Uncertainty exists regarding the best approach for treating bipolar depression among patients already receiving a first-line mood stabilizer. The aim of this pilot study was to compare adding a second mood stabilizer or an antidepressant at this treatment decision point. Methods: Twelve-week, randomized, double-blind pilot trial comparing the addition of lamotrigine or citalopram for bipolar depressed patients on mood stabilizer medication. Change in depressive symptoms and risk of switch were examined. Results: Twenty subjects were randomized. Each treatment group experienced a significant mean reduction in total MADRS scores (citalopram Delta - 14.2, p = 0.002; lamotrigine Delta - 13.3, p = 0.00 1), and there was no significant difference between treatment groups (p=0.78). Total response rates increased from 31.6% at week 6 to 52.6% at week 12. One out of ten patients in each group experienced a switch to hypomania. Limitations: Small sample size. Lack of a placebo arm. Conclusions: Results of this small trial suggest that both larnotrigine and citalopram appear to be reasonable choices as add-on acute treatment for bipolar depression, with response rates continuing to rise considerably past 6 weeks of treatment. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:95 / 99
页数:5
相关论文
共 22 条
[1]   INTERNAL PILOT-STUDIES FOR ESTIMATING SAMPLE-SIZE [J].
BIRKETT, MA ;
DAY, SJ .
STATISTICS IN MEDICINE, 1994, 13 (23-24) :2455-2463
[2]  
Calabrese Joseph R, 2004, J Clin Psychiatry, V65, P571
[3]   A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression [J].
Calabrese, JR ;
Bowden, CL ;
Sachs, GS ;
Ascher, JA ;
Monaghan, E ;
Rudd, GD .
JOURNAL OF CLINICAL PSYCHIATRY, 1999, 60 (02) :79-+
[4]   A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders [J].
Frye, MA ;
Ketter, TA ;
Kimbrell, TA ;
Dunn, RT ;
Speer, AM ;
Osuch, EA ;
Luckenbaugh, DA ;
Corá-Locatelli, G ;
Leverich, GS ;
Post, RM .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2000, 20 (06) :607-614
[5]   Antidepressant-induced mania: an overview of current controversies [J].
Goldberg, JF ;
Truman, CJ .
BIPOLAR DISORDERS, 2003, 5 (06) :407-420
[6]   Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology [J].
Goodwin, GM .
JOURNAL OF PSYCHOPHARMACOLOGY, 2003, 17 (02) :149-173
[7]  
Grunze Heinz, 2002, World J Biol Psychiatry, V3, P115, DOI 10.3109/15622970209150612
[8]   A RATING SCALE FOR DEPRESSION [J].
HAMILTON, M .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1960, 23 (01) :56-62
[9]   Antidepressant-induced mania in bipolar patients: Identification of risk factors [J].
Henry, C ;
Sorbara, F ;
Lacoste, J ;
Gindre, C ;
Leboyer, M .
JOURNAL OF CLINICAL PSYCHIATRY, 2001, 62 (04) :249-255
[10]   Extending indications for long-term pharmacotherapy: Opportunities and challenges [J].
Kane, JM .
AMERICAN JOURNAL OF PSYCHIATRY, 2002, 159 (01) :1-2